Diltiazem

Quick links to important sections

Diltiazem

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diltiazem

Quick Facts

Property Description
Active ingredient Diltiazem hydrochloride
Forms Tablet, Capsule (extended-release), Solution (injection)
Pharmacological class Calcium Channel Blocker (CCB)
Common purpose Management of heart rhythm and circulatory tension
Origin Synthetic (benzothiazepine derivative)

What is Diltiazem and Its Pharmacological Identity?

Diltiazem is a prescription-only medication that contains the active ingredient diltiazem hydrochloride, a synthetic compound derived from the benzothiazepine chemical structure. This substance is fundamentally classified as a cardiovascular drug and belongs to the Calcium Channel Blocker (CCB) class. The Diltiazem formulation is clinically recognized for its balanced therapeutic effects on both the heart's electrical system and peripheral vasculature.

Specifically, Diltiazem is a non-dihydropyridine CCB, a key differentiating factor from other calcium antagonists. This distinction means Diltiazem exerts a moderate, dual influence that is highly valued for its applicability in a typical use scenario where both a reduction in heart rate and vessel relaxation are required. Popular brands containing this INN include Cardizem and Tiazac, reflecting its widespread acceptance.

Diltiazem’s General Purpose and Mechanism of Effect

The general purpose of Diltiazem is to enhance the overall function of the circulatory system by simultaneously reducing heart rate and relaxing blood vessels. It achieves this as a calcium antagonist, inhibiting the movement of calcium into cardiac and vascular cells. This action results in physiological effects, including a negative chronotropic influence (slowing heart rate) and a reduction in peripheral vascular resistance (vasodilation).

This class of compounds is characterized by its simultaneous effect on both the heart's conduction system and the vascular tone. This means the drug helps reduce the workload on the heart while improving blood flow through relaxed arteries.

Available Forms: Immediate-Release Versus Extended-Release

Diltiazem is a single active ingredient product prepared for both oral and intravenous administration. Its dosage form(s) include oral tablets (immediate-release), capsules (extended-release), and an aqueous solution for injection. The key distinction between the oral forms is the release pattern: the extended-release forms are formulated with excipients to ensure a sustained delivery of diltiazem hydrochloride over a full day, offering consistent therapeutic presence.

Regulatory References

  1. Diltiazem - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Diltiazem?

Possible Side Effects and Safety Information

The safety profile of diltiazem hydrochloride is formally categorized by regulatory authorities, with adverse reactions grouped by frequency and the body system affected. Most commonly documented side effects include peripheral edema (swelling, particularly in the legs), headache, and fatigue, which are classified as Common.

Less frequent effects (Uncommon) may include palpitations, bradycardia (slow heart rate), insomnia, and temporary elevations in liver enzymes (transaminases). Rare reactions may involve skin issues like urticaria (hives).

Serious adverse reactions, though rare, are documented in official labeling. These include the development or worsening of congestive heart failure and severe disturbances of the heart’s electrical activity, such as high-degree atrioventricular (AV) block. Severe, potentially life-threatening skin reactions, such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are also officially listed as possible.

Safety notes specify that certain cardiovascular effects, like bradycardia, may be more frequently observed during the initiation of therapy or following a dosage increase. Furthermore, the official label defines strict limitations on use (contraindications). Diltiazem is not intended for use in individuals with pre-existing conditions such as sick sinus syndrome (unless a pacemaker is present) or severe hypotension.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with diltiazem is officially documented to primarily affect the cardiovascular system, requiring prompt medical intervention. The recognized clinical manifestations listed in regulatory labeling include severe bradycardia (abnormally slow heart rate), profound hypotension (low blood pressure), and significant cardiac conduction disturbances, such as second- or third-degree Atrioventricular (AV) block. Additional documented findings may include altered mental status, confusion, and hyperglycemia (elevated blood glucose).

Severe or life-threatening outcomes are recorded in official sources. These serious consequences include the potential for cardiac failure, the development of cardiogenic shock, and in extreme cases, asystole (complete heart stoppage).

Due to the risk of life-threatening events, regulatory authorities mandate that emergency medical help must be sought immediately upon any suspected overdosage. Patients must contact emergency services or a poison control center right away. No specific antidote is known for diltiazem; therefore, management is focused on providing immediate symptomatic and supportive treatment in a hospital setting. This may involve specific interventions such as the use of intravenous calcium salts, vasopressors, or the requirement for continuous ECG monitoring and extended observation, particularly with extended-release formulations.

Therapeutic Uses of Diltiazem

Quick Facts

  • Hypertension (High Blood Pressure): Used to help manage elevated blood pressure levels.
  • Angina: Utilized for the control of chronic stable angina (chest pain) and angina due to coronary artery spasm (Prinzmetal's angina).
  • Arrhythmia: Employed for the temporary control of the rapid ventricular rate in certain heart rhythm disorders, such as atrial fibrillation and atrial flutter.
  • Supraventricular Tachycardia: Indicated for the management of paroxysmal supraventricular tachycardia (PSVT).

Diltiazem is a medication approved for the management of various cardiovascular conditions. Its primary therapeutic domains involve assisting in the control of blood pressure and addressing specific heart-related symptoms. It may be used alone or in combination with other agents for the treatment of hypertension, a condition where lowering blood pressure is vital for reducing the risk of cardiovascular events.

The medication is also indicated to improve daily function in individuals managing chronic stable angina and variant angina. It may help reduce the frequency and severity of chest discomfort associated with these conditions. Additionally, diltiazem is used in hospital settings for the temporary rate control in certain supraventricular tachycardias and other atrial arrhythmias.

Regulatory References

  1. NIH MedlinePlus guidance on Diltiazem

Eligibility and Restrictions for Use

The eligibility for using Diltiazem is strictly determined by regulatory authorities, focusing on a patient's cardiac conduction status and hemodynamic stability. Absolute contraindications prohibit the use of diltiazem in patients with Second- or Third-Degree Atrioventricular (AV) Block or Sick Sinus Syndrome, unless a functioning ventricular pacemaker is present. The medicine is also contraindicated for patients experiencing Severe Hypotension (systolic blood pressure less than 90 mm Hg) or those with Atrial Fibrillation or Flutter combined with an Accessory Bypass Tract (e.g., Wolff-Parkinson-White syndrome).

Regarding age groups, the safety and effectiveness of diltiazem have not been established in the pediatric population (children). Older adults may use the medicine but require caution because they are more likely to have age-related decline in organ function.

Use also requires caution and monitoring in patients with pre-existing Impaired Hepatic Function or Impaired Renal Function. For Pregnancy, official labeling restricts use to only when the potential benefit outweighs the fetal risk. Use during Lactation is generally contraindicated as the drug is excreted in human milk, establishing clear limits on who is officially permitted to use the medicine under labeled conditions.

What should I know about interactions with other medicines?

Diltiazem Interactions with other medicines and products

The official regulatory profile for diltiazem is defined by documented patterns of drug–drug and drug–substance interaction, primarily involving metabolic pathways and cardiac rhythm. All documented constraints are based strictly on regulatory labeling.

Interaction Classifications and Restrictions

Classification Official Regulatory Statement
Contraindicated Combinations Co-administration with Ivabradine is formally prohibited in regulatory labeling. Concurrent use with intravenous beta-blockers is also prohibited.
Metabolic Basis Diltiazem is a moderate inhibitor of CYP3A4 and a weak inhibitor of P-glycoprotein (P-gp). It is also documented as a CYP3A4 substrate itself.
Pharmacodynamic Effects Additive effects on cardiac function occur with Beta-blockers (oral), Digitalis/Digoxin, and Amiodarone, which can result in pronounced bradycardia or conduction disturbances.

Exposure Modification and Substance Interactions

Diltiazem’s inhibition of CYP3A4 and P-gp leads to an increase in the plasma concentrations of many co-administered medications, including drugs like Simvastatin and Cyclosporin. This inhibition is also linked to an increased bleeding risk when diltiazem is co-administered with Direct Oral Anticoagulants (DOACs).

Official labeling advises patients to avoid simultaneous consumption of alcohol with extended-release forms, as alcohol increases the rate and extent of diltiazem exposure. Furthermore, interaction risk, particularly bradycardia with certain agents, is noted as being of specific concern in elderly subjects and patients with hepatic insufficiency.

Mechanism of Action

Calcium Channel Interaction

Diltiazem, a non-dihydropyridine calcium channel blocker, exerts its effect by selectively inhibiting the influx of extracellular calcium ions ( Ca^2+) through voltage-gated L-type calcium channels (VGCCs) located in cardiac and vascular smooth muscle cells. This inhibition reduces intracellular Ca^2+ concentration, which mediates multiple downstream mechanistic consequences.

Effects on Vascular and Cardiac Tissue

In vascular smooth muscle, the reduced calcium availability leads to decreased peripheral vascular resistance through vasodilation. In the myocardium, this action reduces the force of contraction (negative inotropy) and decreases the firing rate of the sinoatrial (SA) node and conduction velocity through the atrioventricular (AV) node (negative chronotropy and dromotropy), collectively decreasing cardiac oxygen demand.

Dosage and Administration Information

How Diltiazem is Used: Official Administration Guidelines

Diltiazem is administered via two primary routes: oral for chronic management and intravenous (IV) for acute, temporary rate control in a hospital setting. The choice of dosage form dictates the dosing frequency and required administration conditions.


Oral Administration Protocol

Dosage Form Frequency and Intake Instructions Starting Dose (Typical) Dosing Adjustments
Extended-Release (ER) Once daily, can generally be taken without regard to meals. 180 mg to 240 mg Titrate slowly, typically waiting 7 to 14 days between increases.
Immediate-Release (IR) Four times daily, prescribed to be taken before meals and at bedtime. 30 mg four times daily The total daily dose may be gradually increased up to a maximum of 360 mg/day.

Important: Extended-release capsules or tablets must be swallowed whole and not crushed or chewed to preserve the sustained-release mechanism.


Intravenous (IV) Administration

The IV route is reserved for temporary control of heart rate in specific arrhythmias (e.g., atrial fibrillation) and requires continuous ECG and blood pressure monitoring in a clinical setting.

  • Loading Dose: An initial bolus of 0.25 mg/kg is given over two minutes, followed by a second bolus (0.35 mg/kg) if required.
  • Maintenance Infusion: A continuous infusion typically starts at 5 mg/hour and can be titrated up to 15 mg/hour. The infusion is intended for temporary use and generally should not exceed 24 hours.

Population Considerations

For older adults and individuals with hepatic impairment, treatment should start at the lowest dose and be increased gradually with close monitoring. Use in the pediatric population is generally not recommended as safety and efficacy have not been established.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Diltiazem

Evidence for use in Hypertension

This section will summarize the types of research, such as randomized controlled trials and observational studies, that have explored the use of Diltiazem for use in the context of high blood pressure and the measures that were assessed in these studies.

Research involving Diltiazem for high blood pressure was conducted in studies focusing on various patient populations. These research efforts explored physiological outcomes, primarily monitoring blood pressure readings over defined time intervals. The research documents data indicating shifts in measured blood pressure within some study participants. Reported measurements during the study period described shifts that were observed in association with the study medication. However, findings were mixed across various studies, and the extent of reported changes may vary significantly depending on the patient group and the specific study design.

Evidence for use in Chronic Stable Angina

This section will present an overview of the research structures, including short-term and intermediate-term trials, that have investigated Diltiazem in relation to functional capacity and symptom metrics related to chronic stable angina.

For conditions characterized by fluctuating or episodic manifestations, research explored outcomes related to physical discomfort and outcomes describing episodic or acute changes. Studies monitored metrics related to symptom frequency during the study period. Research describes measurements of exercise tolerance and other functional measures that were assessed in trials. However, evidence is limited regarding the stability of these findings over long periods. The research does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted.

What is Still Uncertain About Diltiazem

A primary limitation across the body of research is that sample sizes were modest in some trials, meaning the findings may not be widely generalizable. Furthermore, evidence quality varies across studies, and findings were mixed when comparing results from different research groups. What remains uncertain includes a better understanding of long-term outcomes, as follow-up durations were limited, and the optimal role of Diltiazem in patients with complex medical histories. Evidence highlights what is known — and what is still uncertain — about how the medication was studied for both high blood pressure and chronic stable angina.

Frequently Asked Questions (FAQ)

Common questions about Diltiazem (FAQ)


Q: What is the main difference between Diltiazem and other common blood pressure medicines?

Diltiazem belongs to a group of medicines called non-dihydropyridine calcium channel blockers. This class is distinguished by its action on both the heart’s electrical system and the blood vessels. This balanced influence is different from other common blood pressure medicine classes, such as ACE inhibitors (which affect a hormone system) or beta-blockers (which block adrenaline receptors).


Q: Can Diltiazem make you feel tired or dizzy?

Official information lists fatigue (tiredness) as a common side effect of Diltiazem. It can also occasionally lead to symptomatic low blood pressure, which may cause feelings of dizziness. If these effects occur, official information advises patients to take precautions.


Q: What types of foods or drinks should be limited while on Diltiazem?

Regulatory information advises patients taking extended-release Diltiazem to avoid consuming alcohol, as it can increase the concentration of the medication in the bloodstream. Furthermore, grapefruit juice may interfere with the medication's metabolism, potentially increasing Diltiazem levels and effects.


Q: If I already take a statin, is Diltiazem safe to combine with it?

Diltiazem can increase the plasma concentration of certain co-administered medications, including statins like simvastatin. This interaction is due to Diltiazem affecting the drug metabolism pathway (CYP3A4). The potential interaction means that co-administration may require close clinical monitoring and dose consideration by a healthcare professional.


Q: How often do people usually need blood tests while on Diltiazem?

The requirement for routine blood tests is subject to clinical discretion. Official prescribing information notes that Diltiazem can sometimes cause a temporary increase in liver enzymes. Regulatory documents indicate that monitoring, particularly of liver function, may be used as part of the management strategy, especially for individuals with pre-existing hepatic impairment or during therapy initiation.


Q: How does Diltiazem affect athletic performance or exercise tolerance?

Studies examining Diltiazem for conditions like chronic stable angina often measured exercise tolerance as an outcome. These research efforts describe measurements of functional capacity that were assessed during trials. The results reflect the specific conditions under which the studies were conducted.


Q: Can Diltiazem interact with common over-the-counter painkillers like ibuprofen?

Regulatory sources indicate that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may reduce the blood pressure lowering effect of Diltiazem. Co-administration may require close monitoring of blood pressure, as documented in official drug interaction information.


Q: How quickly does Diltiazem start to work after the first dose?

The onset of effect depends on the form used. For the intravenous (IV) injection used in clinical settings, a change in heart rate can occur within a few minutes. The oral forms are intended for sustained, chronic management and are often introduced gradually over a period of time.


Q: If I miss a dose of Diltiazem, what is the generally accepted advice?

Official patient information generally describes taking the dose as soon as it is remembered. However, if it is close to the time of the next scheduled dose, official information notes that the missed dose is usually skipped to avoid double dosing.


Q: What is the connection between Diltiazem and grapefruit?

Grapefruit and grapefruit juice may interfere with the metabolism of Diltiazem in the body. This interaction can potentially increase the amount of Diltiazem in the bloodstream, which may amplify the medication's effects.


Q: Does Diltiazem cause weight gain or loss?

Weight changes are not consistently documented as common or uncommon effects in official labeling. Weight increase has been listed in some regulatory adverse reaction reports, but the frequency is not widely reported across all official documents.


Q: What common supplements or herbal products might interact with Diltiazem?

Diltiazem has the potential to interact with many different substances due to its involvement with the metabolic pathway (CYP3A4). Official information advises caution with herbal supplements, stating there is often insufficient data available to confirm their safety when taken simultaneously with Diltiazem.


Q: How is the mechanism of action of Diltiazem different from an ACE inhibitor?

Diltiazem works as a calcium channel blocker, meaning it prevents calcium from entering heart and blood vessel cells, which relaxes the vessels and slows the heart. Angiotensin-Converting Enzyme (ACE) inhibitors work differently by preventing the formation of a hormone (angiotensin II) that causes blood vessels to narrow.


Q: What are the restrictions on driving or operating machinery while taking Diltiazem?

Regulatory warnings mention that Diltiazem may occasionally cause side effects such as dizziness or symptomatic low blood pressure. Patients are advised to use caution and avoid hazardous tasks such as driving or operating machinery if they experience these effects.


Q: Does Diltiazem affect blood sugar levels?

Though not commonly reported, hyperglycemia (high blood sugar) has been listed as an adverse reaction in some regulatory reports. The frequency of this effect is not widely established across all official documents.


Q: What should be done if I get a bad stomach ache after starting Diltiazem?

Stomach pain or abdominal discomfort is listed as a potential side effect in official safety profiles. Severe abdominal pain is noted as a rare but serious symptom in official safety documents.


Q: Are generic versions of Diltiazem considered the same as the brand name?

Yes, in jurisdictions like the US, the main regulatory body approves generic versions of Diltiazem after certifying they are therapeutically equivalent to the reference brand-name drug. This means they are required to contain the same active ingredient and work in the body in the same way.


Q: Can Diltiazem cause dry mouth?

Dry mouth is listed as an adverse reaction in some regulatory safety profiles. It is considered a rare effect of the medication.


Q: Does Diltiazem interact with supplements like magnesium or calcium?

Official interaction information notes that Diltiazem may interact with calcium supplements, particularly calcium carbonate, which can potentially reduce the medication's effectiveness. The co-administration of these agents may be subject to close monitoring.


Q: Is Diltiazem used to help prevent heart attacks?

Diltiazem is officially used to manage conditions like high blood pressure and angina. Controlling high blood pressure and managing angina are measures that help to reduce the risk of associated cardiovascular events, including heart attacks and strokes.


Q: Why are people told to take Diltiazem at a specific time of day?

Official instructions prescribe immediate-release Diltiazem to be taken four times a day, including before meals and at bedtime. This schedule is generally intended to ensure a consistent and stable concentration of the drug is maintained in the body throughout the 24-hour cycle, which is key for its sustained therapeutic effect.


Q: Is there scientific evidence supporting the use of Diltiazem for heart rhythm issues?

While research summaries in official documents often focus on hypertension and angina, Diltiazem is also clinically used for temporary heart rate control in specific arrhythmias, such as atrial fibrillation. The use for rhythm control is supported by its mechanism of affecting the heart's electrical system.


Q: What are the main reasons a doctor might choose Diltiazem over another drug?

Diltiazem is a non-dihydropyridine calcium channel blocker that is recognized for its unique dual effect. Its action reduces the heart rate while simultaneously relaxing blood vessels. This balanced therapeutic profile is often valued when both reduction in heart rate and improvement in circulation are considerations.

How should Diltiazem be stored and disposed of?

How to Store and Dispose of Diltiazem?

Dosage Form Required Storage Conditions
Oral Forms (Tablets/Capsules) Store at Controlled Room Temperature (20 C to 25 C), protected from excessive humidity. Must be dispensed in a tight, light-resistant container with a child-resistant closure.
Injection Vials (Intact) Store under refrigeration (2 C to 8 C). Do not freeze.

All forms of diltiazem must be kept out of reach of children. The reconstituted injection is stable for 24 hours; any unused portion must be discarded. Disposal of expired or unused oral product must be conducted according to local pharmaceutical waste regulations and should not be flushed down a toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diltiazem found in:

A-Z Index: